Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hong Kong Pharmaceutical Holdings Limited, formerly known as Nam Pei Hong (Holdings) Limited, was a prominent pharmaceutical conglomerate based in Hong Kong. The company specialized in the wholesale and retail of traditional Chinese medicines (TCM), health products, and pharmaceutical distribution within mainland China. Historically listed on the Hong Kong Stock Exchange (Stock Code: 0182), it expanded its operations through significant acquisitions, including interests in biopharmaceutical R&D and retail pharmacy chains in provinces like Guizhou. Following a period of financial restructuring and strategic shifts, the company eventually changed its name to China Health Group Limited in the late 2000s.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hong Kong Pharmaceuticals.